NICE Ltd.
NICE (Nasdaq: NICE) said Bluecrest, a UK health intelligence firm, deployed the NiCE CXone platform with SVL Business Solutions to modernize its contact center. The release cites £250,000 annual savings, a 94% call answer rate, 100% interaction analysis, and coaching-driven product conversations rising from 10% to 70%, contributing to 2,200+ subscriptions.
Friday on the Tel Aviv Stock Exchange, major indices declined. Tel Aviv 35 fell 0.33% to 4,202.63 and Tel Aviv 125 fell 0.31% to 4,074.63. Defense and renewable energy sector indices dropped, while chemicals rubber and plastics rose. FX rates weakened versus the dollar and euro. Bank Hapoalim rose 0.31%, Tower Semiconductor fell 4.35%, Teva fell 2.28%.
NICE Ltd. reported Q2 2026 revenue of $782 million, up 8% year over year, and cloud revenue of $609 million, up 12.6%. Non-GAAP EPS was $2.70. Management cited CX AI and self-service ARR of $362 million (+52%), operating margin of 25.3%, and free cash flow of $93 million. Full-year 2026 revenue guidance is $3.170B to $3.190B.
Over the past 7 days, alphai's AI scored 4 news stories mentioning NICE (NICE Ltd.). Coverage has skewed bullish: 3 bullish, 1 neutral, and 0 bearish.
Recent NICE coverage spans market movers, technology and earnings.
In the last 30 days, NICE insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($100). The most active reporter was Dayan Udi Yehuda, VP, Corporate Finance, with 1 filing.
This is a customer win with quantified outcomes, supportive for NiCE’s CXone demand narrative, but it is not a financial guidance or revenue disclosure.
NICE outperformed strongly on the day, but the article does not cite a specific new catalyst.
Guidance raise plus strong cloud and AI backlog growth supports a near-term positive re-rating, but adoption timing risk could cap upside.
CXone deployment at Currys is presented with measurable service KPIs, supporting NiCE’s customer-experience automation traction narrative.
ESG-report disclosures may support longer-term sentiment and enterprise procurement narratives, but they are not a direct financial catalyst.
alphai scores every news story that mentions NICE with an AI model for sentiment and relevance, and aggregates insider trades from NICE Ltd.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
NICE (Nasdaq: NICE) said Bluecrest, a UK health intelligence firm, deployed the NiCE CXone platform with SVL Business Solutions to modernize its contact center. The release cites £250,000 annual savings, a 94% call answer rate, 100% interaction analysis, and coaching-driven product conversations rising from 10% to 70%, contributing to 2,200+ subscriptions.
4 min readFriday on the Tel Aviv Stock Exchange, major indices declined. Tel Aviv 35 fell 0.33% to 4,202.63 and Tel Aviv 125 fell 0.31% to 4,074.63. Defense and renewable energy sector indices dropped, while chemicals rubber and plastics rose. FX rates weakened versus the dollar and euro. Bank Hapoalim rose 0.31%, Tower Semiconductor fell 4.35%, Teva fell 2.28%.
3 min readNICE Ltd. reported Q2 2026 revenue of $782 million, up 8% year over year, and cloud revenue of $609 million, up 12.6%. Non-GAAP EPS was $2.70. Management cited CX AI and self-service ARR of $362 million (+52%), operating margin of 25.3%, and free cash flow of $93 million. Full-year 2026 revenue guidance is $3.170B to $3.190B.
7 min readNICE (Nasdaq: NICE) said U.K. retailer Currys plc is improving customer engagement using the NiCE CXone platform with partner Concentrix. Reported results include nearly 80% first-contact resolution, contact-to-order ratio of 0.18, six-point NPS gain, complaints down about half over 18 months, and NPS up over 20 points.
2 min readNiCE (Nasdaq: NICE) said it published its 2025 ESG report, prepared with reference to GRI 2021 standards. The company reported expanding responsible AI, including the NiCE Cognigy acquisition, and reinvesting 14% of revenue in R&D. It cited a 23% Scope 1 and 2 emissions reduction in 2025, plus workforce and ethics-training initiatives.
3 min readGlobes reports the Tel Aviv Stock Exchange fell on July 29, with the Tel Aviv 35 down 0.99% and Tel Aviv 125 down 0.96%. Teva Pharmaceutical (NYSE: TEVA; TASE: TEVA) rose 10.17% after Q2 results and raised revenue guidance. Other movers included Enlight Renewable Energy, Elbit Systems, and banks such as Bank Leumi and Hapoalim.
4 min readRBC Capital analyst Rishi Jaluria reiterated a Buy rating on NICE on July 26 and set a $130.00 price target. The article cites TipRanks data on Jaluria’s track record. It also notes Rosenblatt kept a Buy on July 21, while Morgan Stanley downgraded NICE to Hold the same day. NICE reported $766.53M revenue and $46.69M net profit for the quarter ended March 31.
3 min readIsrael stocks fell on Monday. The Tel Aviv 35 Index dropped 2.15% to 4,161.81 and the Tel Aviv 125 Index fell 1.87% to 4,095.62. Chip-related shares led declines: Tower Semiconductor fell 14.56%, Camtek 7.05%, and Nova 7.87%. Nice rose 7.18%. Turnover was NIS 3.98B equities and NIS 5.18B bonds.
2 min readIsrael’s Tel Aviv Stock Exchange rose. Tel Aviv 35 gained 1.39% to 4,193.36 and Tel Aviv 125 rose 1.17% to 4,129.39. Turnover was NIS 4.20B in equities and NIS 7.63B in bonds. Bank Leumi led (+0.80%). Tower Semiconductor jumped 6.44%. Mega Or Holdings fell 5.31% after a halt in permits for new data centers.
3 min readThe article says Micron (MU) reported strong earnings and guidance, but its shares fell after the report due to an 86% gross margin and concerns about AI-driven memory price inflation. It also discusses profit-taking and rotation in AI hardware, potential margin normalization, and undervaluation in software stocks such as CRM, NOW, INTU, and NICE.
4 min read
